🇺🇸 FDA
Patent

US 11819512

Solid forms of a CD73 inhibitor and the use thereof

granted A61KA61K31/282A61K31/555

Quick answer

US patent 11819512 (Solid forms of a CD73 inhibitor and the use thereof) held by Arcus Biosciences, Inc. expires Mon Nov 16 2043 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Arcus Biosciences, Inc.
Grant date
Tue Nov 21 2023 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Nov 16 2043 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
17
CPC classes
A61K, A61K31/282, A61K31/555, A61K31/704, A61K31/706